Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies

Mucormycosis in patients who have COVID-19 or who are otherwise immunocompromised has become a global problem, causing significant morbidity and mortality. Infection is debilitating and fatal, leading to loss of organs and emotional trauma. Radiographic manifestations are not specific, but diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Ram Kumar, Salem-Bekhit, Mounir M., Bhattacharjee, Bedanta, Almoshari, Yosif, Ikbal, Abu Md Ashif, Alshamrani, Meshal, Bharali, Alakesh, Salawi, Ahmad, Widyowati, Retno, Alshammari, Abdulrahman, Elbagory, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468123/
https://www.ncbi.nlm.nih.gov/pubmed/34572661
http://dx.doi.org/10.3390/antibiotics10091079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468123/
https://www.ncbi.nlm.nih.gov/pubmed/34572661
http://dx.doi.org/10.3390/antibiotics10091079

Ejemplares similares